Simplexia
Homepage http://www.simplexia.se
LinkedIn Profile https://linkedin.com/company/s***lex***
HQ Location
Sweden Sweden
Simplexia is develops vaccine against herpes simplex virus type (HSV-2) infection, which is the most common sexually transmitted infection in the world. The infection causes genital herpes with painful and recurrent genital blisters. HSV-2 can also cause life-threatening encephalitis and meningitis in newborns and immunocompromised patients. A major issue is that HSV-2 infected patients also suffer a three-fold increased risk of HIV acquisition.
Biotechnology and Molecular Biology Research
Companies in the biotechnology and molecular biology industry use advanced technologies to research and develop products that are used to diagnose or treat diseases. This also involves gene manipulation which can be used to create new medicines or vaccines.
Career Opportunities at Simplexia
Stay updated on the latest job openings by checking back regularly or by visiting the company's official career page.
No job listings currently found.
Employees of 'Simplexia'
Decision makers at Simplexia
2 Decision Makers at Simplexia
Purchasing & operations at Simplexia
2 Purchasing & Operations at Simplexia
Details of Simplexia
Related Companies and Competitors
Access All Contact Details
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive to ensure that the information is accurate and up-to-date, we cannot guarantee its completeness or accuracy. We do not endorse or guarantee the products or services of any company or individual listed.
